The Departments of Laboratory Medicine and Hematology entered into a partnership with the Social impact foundation MWH4impact on Natural Killer cell therapy.
In a 4-year program MWH4impact financially supports specialized staff to enable the “market-readiness” of the promising Natural Killer (NK) cell therapy product developed in the Radboudumc. This involves the upscaling and implementation strategy of an off-the-shelf NK cell product generated from umbilical cord blood stem cells.
Harry Dolstra, (photo above), Joop Jansen and their team, theme Cancer development and immune defense, have succeeded in growing these NK cells from stem cells in large numbers. They received grants from KWF to examine in patients whether these NK cells can effectively combat leukemia and ovarian cancer cells. Together with MWH4impact they are in an unique position to further develop and bring the NK cell therapy to patients with cancer.
Related news items
Optimal dosing of anti-HIV drug darunavir in pregnant women21 February 2019
In the Journal of Antimicrobial Chemotherapy Stein Schalkwijk, Rob ter Heine, Angela Colbers and David Burger investigated how pregnant women should be treated with the anti-HIV drug darunavir.read more
Celebrations to mark the retirement of Joost Schalkwijk21 February 2019
With a mini symposium (‘Oppervlakkig en toch diepgaand’) and reception a passionate researcher of the RIMLS said farewell. After 36 working years Joost Schalkwijk, theme Inflammatory diseases, will enjoy his retirement.read more
Ultrahigh-resolution MRI reveals structural brain differences in serotonin transporter knockout rats after sucrose and cocaine self-administration20 February 2019
In Addiction Biology Peter Karel and Judith Homberg showed that rats lacking the serotonin transporter show increased cocaine, but unaltered sucrose, self-administration.read more
Standing balance capacity is easily overestimated in well-recovered stroke survivors20 February 2019
In Neurorehabilitation and Neural Repair Jolanda Roelofs and Sander Geurts showed that well-recovered persons in the chronic phase after stroke with clinically no (or only very limited) motor impairment of the affected leg may still show substantial problems with standing balance control.read more
Imprinted genes during early embryonic development18 February 2019
René Dirks, with other members from the lab of Hendrik Marks, theme Cancer development and immune defense, show in a paper in Epigenetics & Chromatin that genomic imprinting (genes expressed from the paternal or maternal allele only) is often lost in cultured embryonic stem cells.read more